PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-85

  1. 137 Posts.
    lightbulb Created with Sketch. 163
    I don’t see why they would require their regulatory consultants to review if it was a straight forward yes and IND application open. I wish I could share your optimism, however, my expectations remain tempered
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.